JERUSALEM--(BUSINESS WIRE)--Mar. 31, 2015-- Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge® (amlodipine and valsartan) Tablets in four ...

Par announced the launch of Amlodipine and Valsartan Tablets, the generic version of Novartis’ Exforge. The Food and Drug Administration (FDA) granted final approval for its Abbreviated New Drug ...

New Strength for Nuvigil Launched Teva announced the launch of Amlodipine and Valsartan Tablets, the generic version of Novartis' Exforge. Teva announced the launch of Amlodipine and Valsartan Tablets ...

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge HCT® (Amlodipine, Valsartan, Hydrochlorothiazide) Tablets in the ...

India's Lupin launched a generic drug tablet in the U.S. combining hypertension drugs Amlodipine and Valsartan tablets.The drug is a generic version of Novartis AG's Exforge tablets, Lupin said. The U ...

Nov. 11, 2005 — The U.S. Food and Drug Administration (FDA) has approved first-time generic formulations of glimepiride 1-, 2-, and 4-mg tablets and first-time doses of 3-, 6-, and 8-mg tablets for ...

(Reuters) - Swiss drugmaker Novartis AG has agreed to pay $30 million to settle claims by health plans and consumers that it schemed to delay the U.S. launch of generic competition for its Exforge ...

MUMBAI (Reuters) - Indian drug maker Ranbaxy Laboratories Ltd said on Tuesday it had received clearance from Japan's ministry of health and labour welfare for generic hypertension drug amlodipine ...

The FINANCIAL — Teva Pharmaceutical Industries Ltd., on November 7 announced approval of generic Tribenzor (olmesartan medoxomil, amlodipine and hydrochlorothiazide) tablets in the U.S. and is in the ...

Pharmacist-compares-drugs_G_90139450 Switching back to branded drugs is more likely in generic drug than authorized generic drugs. Patients who switch from branded drugs are more likely to switch back ...

The FINANCIAL — Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) announces the launch of the generic equivalent to Exforge (amlodipine and valsartan) Tablets in four different strengths, in the United ...